Skip to main content
Oxford Medical Case Reports logoLink to Oxford Medical Case Reports
. 2025 Jan 18;2025(1):omae161. doi: 10.1093/omcr/omae161

Primary purulent bacterial pericarditis due to Streptococcus intermedius in the absence of an esophago-pericardial fistula

Sahil M Patel 1,✉, Varshini Venkatesan 2, Elaine Simon 3, Stephen Hull 4
PMCID: PMC11748439  PMID: 39839688

Abstract

Purulent bacterial pericarditis is a rare and progressive infection with a high mortality. It is rarely due to Streptococcus intermedius, a commensal bacteria found in the oral cavity, gastrointestinal tract, and the genitourinary tract. Here we present a 71-year-old man with history of esophageal adenocarcinoma, status post distal esophagectomy and proximal gastrectomy 2 years prior, who developed cardiac tamponade secondary to primary S. intermedius purulent bacterial pericarditis in the absence of an esophago-pericardial fistula. We discuss the clinical manifestations of bacterial pericarditis and pericardial effusions, useful diagnostic tools, and explore possible mechanisms for S. intermedius pericarditis infection. This case highlights the importance of prompt suspicion, recognition, and intervention for bacterial pericarditis and cardiac tamponade in the setting of recent esophageal instrumentation. In addition, despite being rare, S. intermedius should be recognized as a possible pathogen in purulent bacterial pericarditis even with the absence of an esophago-pericardial fistula.

Keywords: pericarditis, esophageal neoplasms, S. intermedius, cardiac tamponade

Introduction

Pericardial effusions caused by infection can result in bacterial pericarditis and in rare instances, develop purulent bacterial pericarditis, which has a high mortality [1]. The most common bacteria involved include Streptococci, Staphylococci, Haemophilus, and Mycobacterium tuberculosis [1]. Streptococcus anginosus group (SAG), previously known as S. milleri group, includes S. intermedius, S. constellatus, and S. anginosus [2]. These commensal bacterial species are naturally found in the oral cavity, gastrointestinal tract, and the genitourinary tract and when compared to other alpha hemolytic streptococci species, have a propensity for more invasive infections [3]. They have a proclivity to form abscesses in the brain, lung, liver, and abdomen, but rarely have led to purulent bacterial pericarditis [2]. Only 7 cases of S. intermedius pericarditis have been reported between since 1984 [1, 4]. Most cases of primary SAG bacterial pericarditis are due to direct spread via an esophago-pericardial fistula, which is a dreaded complication of esophageal carcinoma [5]. Here we present a unique case of primary S. intermedius purulent bacterial pericarditis in a patient without any evidence of an esophago-pericardial fistula.

Case report

A 71-year-old man with history of stage IV prostate cancer with bone metastases and esophageal adenocarcinoma status post distal esophagectomy and proximal gastrectomy presented to the emergency department for evaluation of weakness and odynophagia. He reported that his odynophagia may be secondary to his esophageal stent, thus resulting in an inability to tolerate oral intake. He had required numerous esophageal stents over the past 2 years for a recurrent esophageal stricture which developed after his esophageal adenocarcinoma resection. His most recent esophageal stent had been placed 2 months ago. Due to his persistently poor oral intake, he was being evaluated by outpatient surgery for a feeding tube. He had also received whole chest radiation and immunotherapy for his esophageal adenocarcinoma. He denied any dyspnea or chest pain.

On presentation, his vital signs were significant for temperature 101.8°F, heart rate 104 beats per minute (bpm), and blood pressure 70/54 mmHg. Initial lab work was significant for white blood cell count 13.5 × 109/L, hemoglobin 10.5 g/dL, hematocrit 32.1%, albumin 2.2 g/dL, alkaline phosphatase 306 U/L, and procalcitonin 710 ng/L. Urinalysis showed no signs of infection. Electrocardiogram (EKG) was unremarkable compared to prior EKGs. Computed tomography (CT) of the chest, abdomen, and pelvis showed a large pericardial effusion with concentric smooth rim enhancement concerning for an infectious pericarditis (Fig. 1), bilateral small pleural effusions with bibasilar compression atelectasis and scarring, and a metallic distal esophageal stent with internal air-fluid level. At this time, cardiology and oncology were consulted.

Figure 1.

Figure 1

CT scan of the chest showing a large pericardial effusion with maximal thickness of 27.8 mm.

Shortly afterwards, the patient developed a wide-complex tachycardia. An emergent transthoracic echocardiogram redemonstrated a large circumferential pericardial effusion with new evidence of cardiac tamponade. He subsequently underwent emergent bedside pericardiocentesis with removal of 700 cc of purulent fluid with quick improvement in his hemodynamic status. Pericardial fluid was sent to pathology where no malignancy was seen on cytology or cell block, thus raising concern for an infectious etiology. Pericardial fluid gram stain showed many white blood cells, no epithelial cells and no organisms. Pericardial fluid culture was positive for S. intermedius. Blood cultures obtained on admission showed no growth at five days. He was started on 2 grams of intravenous ceftriaxone. Once he was stabilized, a CT chest with oral contrast was performed which showed no oral contrast extravasation in the pericardial or pleural space, confirming the absence of an esophageal stent leak or esophago-pericardial fistula. Therefore, we diagnosed him with primary S. intermedius purulent bacterial pericarditis in the absence of an esophago-pericardial fistula.

Later on, during his hospitalization, the patient went into cardiac arrest due to ventricular tachycardia. Return of spontaneous circulation was achieved, but given his clinical decline, his family ultimately decided to pursue hospice care. The patient died shortly afterwards.

Discussion

With the use of broad-spectrum antibiotics, bacterial pericarditis is rare and typically occurs only in immunocompromised patient or those with underlying pericardial disease [6]. It is usually a secondary infection caused by hematogenous dissemination or contiguous spread from surrounding intrathoracic infection, usually from the lung or pleura [1, 7]. Purulent bacterial pericarditis, characterized by frank pus in the pericardial cavity, is a serious manifestation of bacterial pericarditis [1]. Mortality rates approach 100% if it is not identified and treated quickly, but even when identified early, the mortality rate is as high as 40%, likely due to complications like cardiac tamponade, sepsis, and constriction [1, 8, 9].

The classic manifestations of bacterial pericarditis are not always seen as patients present with nonspecific signs and symptoms [1]. Almost all patients present with fever, 25%–37% present with either pleuritic or nonpleuritic chest pain, and less than 50% present with pericardial friction rub and pulsus paradoxus [1, 7]. Lab work can show signs of inflammation, leukocytosis and an elevated troponin in 50% of cases [9, 10]. Cardiomegaly can be seen on chest radiograph along with pleural effusion, pulmonary infiltrates, and mediastinal widening [9]. Approximately 10%–35% of patients have a normal EKG, not showing the classic diffuse ST-segment elevation [7, 9]. Transthoracic echocardiogram is the most sensitive test for pericardial effusions as it can identify evidence of cardiac tamponade, which requires emergent pericardiocentesis [1]. The presence of purulent fluid, however, requires a pericardiocentesis as well. Pericardial fluid should be sent for cell count, Gram, fungal, and acid-fast stain, and culture [1]. Broad-spectrum antibiotics with an antistaphylococcal agent and an aminoglycoside are warranted [1]. This can be narrowed further based on culture and sensitivity results.

With our patient’s negative blood cultures and imaging, he was diagnosed with primary S. intermedius purulent bacterial pericarditis. S. intermedius is known to spread from the gastrointestinal tract to the pericardial space via esophago-pericardial fistulas. As no evidence for an esophago-pericardial fistula was found, the mechanism behind how S. intermedius infected the pericardium of our patient is unclear. Genetic studies have shown that S. intermedius has the presence of spreading factors, invasion proteins, adhesions, the Streptococcus invasion locus (Sil) two-component regulator of virulence, and cell wall proteins [3]. However, the possibility that this species evolved to develop a new mechanism of transfer allowing it to be more virulent cannot be ruled out. Given the patient’s immunocompromised status, another hypothesis involves the presence of micro-perforations during his esophageal stenting procedures which possibly led to seeding into the bloodstream. A peculiar finding however, was the lack of any grown on his blood cultures.

This case highlights the importance of prompt suspicion, recognition, and intervention for bacterial pericarditis and cardiac tamponade in the setting of recent esophageal instrumentation. In addition, despite being rare, S. intermedius should be recognized as a possible pathogen in purulent bacterial pericarditis even with the absence of an esophago-pericardial fistula.

Consent

Informed consent for publication was obtained for this case report.

Guarantor

Stephen D. Hull, Internal Medicine, Grandview Medical Center, 3690 Grandview Parkway, Birmingham, AL. 35 243. United States. Tel: (228) 596-5068. Email: hull.sd@gmail.com

Acknowledgements

The authors would like to acknowledge Connor Griggs, MD for providing radiological reads of the image provided.

Contributor Information

Sahil M Patel, Internal Medicine, Brookwood Baptist Health, 833 Princeton Ave. SW, POB 3, Suite 200E, Birmingham, AL 35211, United States.

Varshini Venkatesan, Internal Medicine, Brookwood Baptist Health, 833 Princeton Ave. SW, POB 3, Suite 200E, Birmingham, AL 35211, United States.

Elaine Simon, Internal Medicine, Brookwood Baptist Health, 833 Princeton Ave. SW, POB 3, Suite 200E, Birmingham, AL 35211, United States.

Stephen Hull, Internal Medicine, Grandview Medical Center, 3690 Grandview Parkway, Birmingham, AL 35243, United States.

Conflict of interest

The authors disclose no conflicts of interest.

Funding

The authors disclose no financial support.

Ethical approval

No approval is required.

References

  • 1. Khan  MS, Khan  Z, Banglore  BS. et al.  Primary purulent bacterial pericarditis due to Streptococcus intermedius in an immunocompetent adult: a case report. J Med Case Rep  2018;12:27. 10.1186/s13256-018-1570-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Faden  HS. Infections associated with Streptococcus intermedius in children. Pediatr Infect Dis J  2016;35:1047–8. 10.1097/INF.0000000000001227. [DOI] [PubMed] [Google Scholar]
  • 3. Denby  KJ, Byrne  RD, Gomez-Duarte  OG. Streptococcus intermedius: an unusual case of purulent pericarditis. Case Rep Infect Dis  2017;2017:5864694. 10.1155/2017/5864694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Christian-Miller  N, Goraya  S, O'Hayer  P. et al.  Purulent Streptococcus intermedius pericarditis in the setting of Histoplasma mediastinal lymphadenitis: a case report and literature review. Cureus  2024;16:e62626. 10.7759/cureus.62626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Muto  M, Ohtsu  A, Boku  N. et al.  Streptococcus milleri infection and pericardial abscess associated with esophageal carcinoma: report of two cases. Hepato-Gastroenterology  1999;46:1782–4. [PubMed] [Google Scholar]
  • 6. Hall  IP. Purulent pericarditis. Postgrad Med J  1989;65:444–8. 10.1136/pgmj.65.765.444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Rubin  RH, Moellering  RC  Jr. Clinical, microbiologic and therapeutic aspects of purulent pericarditis. Am J Med  1975;59:68–78. 10.1016/0002-9343(75)90323-x. [DOI] [PubMed] [Google Scholar]
  • 8. Keersmaekers  T, Elshot  SR, Sergeant  PT. Primary bacterial pericarditis. Acta Cardiol  2002;57:387–9. 10.2143/AC.57.5.2005459. [DOI] [PubMed] [Google Scholar]
  • 9. Pankuweit  S, Ristic  AD, Seferovic  PM. et al.  Bacterial pericarditis: diagnosis and management. Am J Cardiovasc Drugs  2005;5:103–12. 10.2165/00129784-200505020-00004. [DOI] [PubMed] [Google Scholar]
  • 10. Bonnefoy  E, Godon  P, Kirkorian  G. et al.  Serum cardiac troponin I and ST-segment elevation in patients with acute pericarditis. Eur Heart J  2000;21:832–6. 10.1053/euhj.1999.1907. [DOI] [PubMed] [Google Scholar]

Articles from Oxford Medical Case Reports are provided here courtesy of Oxford University Press

RESOURCES